Clinician Discussion of Family Cancer Risk and Use of Genetic Testing Among US Adults With a Family History of Cancer
Preventing Chronic Disease · 2026
DOI: 10.5888/pcd23.260179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Preventing Chronic Disease, 2026. Verfasst von Abe E Sahmoun. Beteiligte Einrichtung: Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota. Hauptthemen laut MEDLINE: Genetic Testing, Neoplasms, Genetic Predisposition to Disease, Physician-Patient Relations. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Family history plays a key role in assessing inherited cancer risk, but genetic testing is still underused at the population level. The role of clinician-patient discussion in this gap is not well characterized. This study aimed to evaluate the association between clinician discussion of family cancer risk and use of genetic testing among US adults with a first-degree family history of cancer.
Methods
This cross-sectional study used data from the 2023 National Health Interview Survey. The exposure was self-reported clinician discussion of family cancer risk, and the outcome was self-reported receipt of genetic testing for cancer risk. Survey weights were applied to generate nationally representative estimates. Propensity scores were used to match respondents with and without clinician discussion. Survey-weighted logistic regression models estimated associations.
Results
Among 9,476 respondents (representing approximately 72.6 million US adults), 50% reported clinician discussion, and 7.8% reported genetic testing. Testing was more common among those reporting discussion (12.9%) than those who did not (2.7%) (P < .001). In fully adjusted analyses, clinician discussion was associated with higher odds of testing (adjusted odds ratio, 5.35; 95% CI, 4.23-6.76). Older age, female sex, higher education, and personal cancer history were also associated with testing.
Conclusion
Clinician discussion of family cancer risk was strongly associated with use of genetic testing; however, overall testing rates were low. Improving routine clinician engagement may increase use of genetic services and support cancer prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Internal Medicine, University of North Dakota School of Medicine and Health Sciences, Fargo, North Dakota.
Zitieren
APA
Sahmoun, A. E. (2026). Clinician Discussion of Family Cancer Risk and Use of Genetic Testing Among US Adults With a Family History of Cancer. Preventing Chronic Disease. https://doi.org/10.5888/pcd23.260179
Vancouver
Sahmoun AE. Clinician Discussion of Family Cancer Risk and Use of Genetic Testing Among US Adults With a Family History of Cancer. Preventing Chronic Disease. 2026. doi:10.5888/pcd23.260179
BibTeX
@article{Sahmoun2026,
author = {Sahmoun, Abe E},
title = {Clinician Discussion of Family Cancer Risk and Use of Genetic Testing Among US Adults With a Family History of Cancer},
journal = {Preventing Chronic Disease},
year = {2026},
doi = {10.5888/pcd23.260179}
}
EUVIMED